Article
Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence.
International journal of molecular sciences - 9 Jan 2020
Jha Ruchira M, Bell Josh, Citerio Giuseppe, Hemphill J Claude, Kimberly W Taylor, Narayan Raj K, Sahuquillo Juan, Sheth Kevin N, Simard J Marc
Abstract excerpt
Cerebral edema and contusion expansion are major determinants of morbidity and mortality after TBI. Current treatment options are reactive, suboptimal and associated with significant side effects. First discovered in models of focal cerebral ischemia, there is increasing evidence that the sulfonylurea receptor 1 (SUR1)-Transient receptor potential melastatin 4 (TRPM4) channel plays a key role in these critical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
